Licochalcone A Inhibits Prostaglandin E2 by Targeting the MAPK Pathway in LPS Activated Primary Microglia
Molecules · 2023
DOI: 10.3390/molecules28041927 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Harsharan Singh Bhatia und 5 weiteren Autor:innen. Beteiligte Einrichtung: Neuroimmunology and Neurochemistry Research Group, Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medi…. Hauptthemen laut MEDLINE: Mitogen-Activated Protein Kinases, Microglia. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alzheimer Forschung Initiative, Alzheimer Forschung Initiative e.V. (AFI).
Abstract (Originalsprache)
Neuroinflammation and oxidative stress are conditions leading to neurological and neuropsychiatric disorders. Natural compounds exerting anti-inflammatory and anti-oxidative effects, such as Licochalcone A, a bioactive flavonoid present in a traditional Chinese herb (licorice), might be beneficial for the treatment of those disorders. Therefore, this study aimed to investigate the anti-inflammatory and anti-oxidative effects of Licochalcone A in LPS-activated primary rat microglia. Licochalcone A dose-dependently prevented LPS-induced PGE2 release by inhibiting the arachidonic acid (AA)/cylcooxygenase (COX) pathway decreasing phospholipase A2, COX-1, and COX-2 protein levels. Furthermore, LPS-induced levels of the cytokines IL-6 and TNFα were reduced by Licochalcone A, which also inhibited the phosphorylation and, thus, activation of the mitogen-activated protein kinases (MAPK) p38 MAPK and Erk 1/2. With the reduction of 8-iso-PGF2α, a sensitive marker for oxidative stress, anti-oxidative effects of Licochalcone A were demonstrated. Our data demonstrate that Licochalcone A can affect microglial activation by interfering in important inflammatory pathways. These in vitro findings further demonstrate the potential value of Licochalcone A as a therapeutic option for the prevention of microglial dysfunction related to neuroinflammatory diseases. Future research should continue to investigate the effects of Licochalcone A in different disease models with a focus on its anti-oxidative and anti-neuroinflammatory properties.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Neuroimmunology and Neurochemistry Research Group, Department of Psychiatry and Psychotherapy, Medical Center-University of Freiburg, Faculty of Medicine, University of Freiburg, D-79104 Freiburg, Germany.
- Institute for Tissue Engineering and Regenerative Medicine (iTERM), Helmholtz Zentrum München, 85764 Neuherberg, Germany.
- Institute for Stroke and Dementia Research, Klinikum der Universität München, Ludwig Maximilian University of Munich (LMU), 81377 Munich, Germany.
ORCID-Profile: Bernd L Fiebich
Förderung
- Alzheimer Forschung Initiative
- Alzheimer Forschung Initiative e.V. (AFI)
Zitieren
APA
Bhatia, H. S., Apweiler, M., Sun, L., Baron, J., Tirkey, A., & Fiebich, B. L. (2023). Licochalcone A Inhibits Prostaglandin E2 by Targeting the MAPK Pathway in LPS Activated Primary Microglia. Molecules. https://doi.org/10.3390/molecules28041927
Vancouver
Bhatia HS, Apweiler M, Sun L, Baron J, Tirkey A, Fiebich BL. Licochalcone A Inhibits Prostaglandin E2 by Targeting the MAPK Pathway in LPS Activated Primary Microglia. Molecules. 2023. doi:10.3390/molecules28041927
BibTeX
@article{Bhatia2023,
author = {Bhatia, Harsharan Singh and Apweiler, Matthias and Sun, Lu and Baron, Julian and Tirkey, Ashwini and Fiebich, Bernd L},
title = {Licochalcone A Inhibits Prostaglandin E2 by Targeting the MAPK Pathway in LPS Activated Primary Microglia},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28041927}
}
EUVIMED